Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Conditions: Atherosclerosis of Artery; Coronary Artery Disease; Peripheral Arterial Disease; Carotid Stenosis Intervention: Drug: Rivaroxaban 2.5mg Sponsors: Asan Medical Center; Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
Condition: AERD - Aspirin Exacerbated Respiratory Disease Interventions: Drug: Aspirin 300 Mg Oral Tablet; Drug: Placebo Sponsor: Lucyna Mastalerz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Conditions: Atherosclerosis of Artery; Coronary Artery Disease; Peripheral Arterial Disease; Carotid Stenosis Intervention: Drug: Rivaroxaban 2.5mg Sponsors: Asan Medical Center; Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
Condition: AERD - Aspirin Exacerbated Respiratory Disease Interventions: Drug: Aspirin 300 Mg Oral Tablet; Drug: Placebo Sponsor: Lucyna Mastalerz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Conditions: Atherosclerosis of Artery; Coronary Artery Disease; Peripheral Arterial Disease; Carotid Stenosis Intervention: Drug: Rivaroxaban 2.5mg Sponsors: Asan Medical Center; Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
Condition: AERD - Aspirin Exacerbated Respiratory Disease Interventions: Drug: Aspirin 300 Mg Oral Tablet; Drug: Placebo Sponsor: Lucyna Mastalerz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Conditions: Atherosclerosis of Artery; Coronary Artery Disease; Peripheral Arterial Disease; Carotid Stenosis Intervention: Drug: Rivaroxaban 2.5mg Sponsors: Asan Medical Center; Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
Condition: AERD - Aspirin Exacerbated Respiratory Disease Interventions: Drug: Aspirin 300 Mg Oral Tablet; Drug: Placebo Sponsor: Lucyna Mastalerz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Conditions: Atherosclerosis of Artery; Coronary Artery Disease; Peripheral Arterial Disease; Carotid Stenosis Intervention: Drug: Rivaroxaban 2.5mg Sponsors: Asan Medical Center; Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial
The objective of this study is to evaluate the efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with CHD and GID undergoing PCI. We aim to explore an optimized antithrombotic strategy, which achieves the same anti-ischemic effect as standard DAPT without increasing the risk of GIB, for patients with CHD and GID undergoing PCI.Trial registrationThis protocol is registered at the Chinese Clinical Trial Registry under the number ChiCTR2100044319. And this publication is based on version 1.4 of the trial protocol dated Sep 6, 2021. (Source: Trials)
Source: Trials - March 21, 2023 Category: Research Source Type: clinical trials
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
ConclusionsDaily aspirin significantly reduces U-TXM in participants with diabetes, including at 12 –24 h after ingestion.Trial registrationISRCTN ISRCTN60635500. Registered on 1 Sept 2005; ClinicalTrials.gov NCT00135226. Registered on 24 Aug 2005. (Source: Trials)
Source: Trials - March 4, 2023 Category: Research Source Type: clinical trials
A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease
Conditions: Sarpogrelate; Blood Viscosity; Peripheral Arterial Disease; Coronary Artery Disease Interventions: Drug: Sarpogrelate Sustained Release/Aspirin; Drug: Aspirin Sponsor: Yuhan Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2023 Category: Research Source Type: clinical trials
